Physician profile
Micah D Riegner
NPI 1073512802
$872.02
in general payments reported to CMS, 2019-2025
17 companies · $303 in 2025
The $303 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.34 · 2020: $44.62 · 2021: $111 · 2022: $85.75 · 2023: $74.18 · 2024: $185 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438 · Long Term Medical Supply Or Device Loan: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.43 |
| Long Term Medical Supply Or Device Loan | $123.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $130.25 | 2019-2024 | Jornay Pm |
| Baxter Healthcare | $123.96 | 2025 | Hillrom - Spot Vision Screener |
| Corium, LLC | $97.21 | 2021-2025 | Azstarys |
| Sanofi Pasteur INC. | $80.43 | 2019-2024 | |
| Sobi, INC | $73.53 | 2019-2023 | |
| Pfizer INC. | $59.58 | 2021-2025 | |
| Glaxosmithkline, LLC. | $56.00 | 2019-2024 | Rotarix |
| Supernus Pharmaceuticals, INC. | $41.48 | 2021-2022 | |
| Adlon Therapeutics L.P. | $30.09 | 2020-2021 | |
| Ars Pharmaceuticals Operations, INC. | $27.80 | 2025 | Neffy |
| Sanofi-Aventis U.S. LLC | $25.17 | 2024 | |
| Acadia Pharmaceuticals INC | $25.14 | 2024 | Daybue |
| Collegium Pharmaceutical, INC. | $24.69 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $23.75 | 2019-2020 | |
| Tris Pharma INC | $20.10 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $18.91 | 2025 | Flucelvax |
| Biomarin Pharmaceutical INC. | $13.93 | 2025 | Voxzogo 1.2mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micah Riegner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.